<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02902276</url>
  </required_header>
  <id_info>
    <org_study_id>P/2016/187</org_study_id>
    <nct_id>NCT02902276</nct_id>
  </id_info>
  <brief_title>Link Between Plasma Citrulline and Lipopolysaccharide Concentrations in the Critically Ill</brief_title>
  <acronym>CITRANS</acronym>
  <official_title>Link Between Plasma Citrulline and Lipopolysaccharide Concentrations in the Critically Ill</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In critically ill patients, the small bowel permeability is increased, leading to bacterial
      translocation, and systemic inflammatory response syndrome.

      Plasma citrulline is a validated biomarker of functional enterocyte mass. Lipopolysaccharide
      (LPS) is a part of Gram negative bacteria, and plasma LPS concentration is a biomarker of
      bacterial translocation. The link between plasma citrulline and LPS in the critically ill is
      unknown. Investigators hypothesize that patients presenting with low plasma citrulline
      concentration, with presumed altered small bowel function, would have an increased phenomenon
      of bacterial translocation, and increased plasma LPS concentration. Investigators aimed to
      evaluate the link between plasma citrulline and LPS concentrations in critically ill patients
      at the time of ICU admission.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma citrulline concentration</measure>
    <time_frame>Up to 12 hours after admission in the unit</time_frame>
    <description>biological assay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>plasma lipopolysaccharide concentration</measure>
    <time_frame>Up to 12 hours after admission in the unit</time_frame>
    <description>biological assay</description>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Critically Ill</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>additional blood sample</intervention_name>
    <description>Two blood samples will be taken at ICU admission</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      2000 microliters of plasma will be stored at -80°C for future analyses (lipopolysaccharide
      concentration, cytokines).
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill patients requiring ICU admission for at least 48 hours, without chronic
        small bowel disease, without chronic renal failure (usual clearance of creatinine &lt; 50
        mL/min), not pregnant.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Critically ill patients requiring ICU admission for at least 48 hours

          -  Adults

        Exclusion Criteria:

          -  Chronic small bowel disease

          -  Chronic renal failure (clearance of creatinine &lt; 50 mL/min)

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaël Piton, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Besançon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gaël Piton, MD, PhD</last_name>
    <phone>0033381668224</phone>
    <email>gpiton@chu-besancon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaël PITON, MD, PhD</last_name>
      <phone>0033381668224</phone>
      <email>gpiton@chu-besancon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>September 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2016</study_first_posted>
  <last_update_submitted>September 14, 2016</last_update_submitted>
  <last_update_submitted_qc>September 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>plasma citrulline</keyword>
  <keyword>lipopolysaccharide</keyword>
  <keyword>critically ill</keyword>
  <keyword>Hospitalization in an Intensive Care Unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

